Wall St. Before Main St. for H1N1 Vaccine?

The dilemma over how limited supplies of the H1N1 vaccine should be distributed was underscored today as government health officials defended their allocation of vaccine to Wall Street firms. But doctors around the country bristled at this news, asking why these firms can get the vaccine while physicians and hospitals still face shortages. It is a controversy that prompted a comment from the White House, a letter from the CDC, and protest to congress from a citizens group. "Greed goes beyond...Full Story
Commenting on this article is closed.